By Dr Shane Oliver, Chief Economist and Head of Investment Strategy at AMP. Investment markets and key developments Global ...
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) and Amicus Therapeutics (Nasdaq: FOLD) announced today that BioMarin has entered into a definitive agreement to acquire Amicus for $14.50 per share in an ...
China’s export controls heightened supply risks, pushing rare earths and critical metals into strategic focus. ・U.S. policy ...
Toddlers and younger viewers will love watching Curious George and the Man in the Yellow Hat as they seek out the perfect ...